Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106854206B reveals novel fluoroquinolone thiourea synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with high-purity scalable routes.
Patent CN119899823A reveals a novel lipase mutant enabling mild, cost-effective production of chiral pharmaceutical intermediates with superior stereoselectivity.
Patent CN107746861A details a biocatalytic route for high-purity chiral alcohols. Discover cost-effective supply chain solutions for API intermediates.
Advanced solid-phase synthesis method for Leuprorelin acetate reducing side reactions and improving yield. Ideal for pharmaceutical intermediate supply chain optimization.
Patent CN1271057C details a cost-effective Meptazinol Hydrochloride synthesis. Discover supply chain advantages and high-purity manufacturing insights.
Patent CN113999146B reveals a novel aqueous oxidation route for 4-guanidinobutyric acid. Discover cost-effective manufacturing and reliable supply chain solutions for this key pharma intermediate.
Patent CN102633614A reveals green catalytic oxidation for TMBQ. Enhances supply chain reliability and reduces manufacturing costs for vitamin E intermediates significantly.
Patent CN106748768B details a mild Ni-catalyzed synthesis for chiral esters, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107033073A reveals catalyst-free synthesis route. Delivers high purity pharmaceutical intermediates with reduced environmental impact and supply chain reliability.
Advanced synthesis of 2-amino-3 5-dibromopyrazine via CN110878056A. Enhanced purity and yield for pharmaceutical intermediates. Reliable supply chain solutions.
Patent CN1840671A details a bio-catalytic route for (R)-mandelic acid using Brevibacterium flavum. Offers high optical purity and greener manufacturing for pharmaceutical supply chains.
Patent CN115043704A reveals a novel Rh-catalyzed kinetic resolution for high-purity gem-difluoro cyclopropane intermediates, offering significant supply chain and cost advantages.
Patent CN108069869B reveals a cyanide-free route for Apalutamide. Discover cost reduction in API manufacturing and high-purity supply chain solutions.
Patent CN102924439B details a novel one-step base catalytic method for Iloperidone. Achieves over 90% yield and 99% purity, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN102234238B reveals a mild Raney-Ni catalyzed route for Agomelatine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN104193792B reveals a one-step microwave-assisted conversion of chenodeoxycholic acid. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity ursodeoxycholic acid.
Discover the advanced synthetic method for A-nor-3,5-cracking-androstane-5-ketone-3,17 beta-diacid. Enhance supply chain reliability and reduce manufacturing costs with green chemistry.
Patent CN103059027A details a high-yield Tebipenem Pivoxil route eliminating column chromatography, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN106518879A reveals a novel synthesis for quinazoline derivatives with superior liver cancer activity, offering cost-effective supply chain solutions.
Novel direct salting-out process reduces solvent residue and simplifies manufacturing for high-purity cephalosporin intermediates and APIs.